您的位置: 首页 > 农业专利 > 详情页

HUMAN MONOCLONAL ANTIBODIES TO CTLA-4
专利权人:
Pfizer Inc.;Amgen Fremont Inc.
发明人:
Hanson, Douglas Charles,Neveu, Mark Joseph,Mueller, Eileen Elliot,Hanke, Jeffrey Herbert,Gilman, Steven Christopher,Davis, C. Geoffrey,Corvalan, José Ramon
申请号:
EP20090007161
公开号:
EP2112166(B1)
申请日:
1999.12.23
申请国别(地区):
欧洲专利局
年份:
2018
代理人:
摘要:
In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充